Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis

Biological Research

Volumn 45, Issue 3, 2012, Pages 257-268

  Rivera, Francisco J ^a   Aigner, Ludwig ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Mesenchymal stem cell therapy and functional recovery; Multiple sclerosis; Oligodendrocyte progenitor cells; Remyelination

Indexed keywords

ADULT; ARTICLE; CELL DIFFERENTIATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY;

ADULT; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION;

ANIMALIA;

EID: 84871491642     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602012000300007     Document Type: Article

References (181)

1. AGGARWAL S, PITTENGER MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-22.
2. AHLGREN SC, WALLACE H, BISHOP J, NEOPHYTOU C, RAFF MC (1997) Effects of Thyroid Hormone on Embryonic Oligodendrocyte Precursor Cell Developmentin Vivoandin Vitro. Molecular and Cellular Neuroscience 9: 420-432.
3. ALLAMARGOT C, POUPLARDB-ARTHELAIX A, FRESSINAUD C (2001) A single intracerebral microinjection of platelet-derived growth factor (PDGF) accelerates the rate of remyelination in vivo. Brain Research 918: 28-39.
4. ALONSO A, HERNÁN MA (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71: 129-35.
5. ALTMAN J (1969) Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol. 137: 433-57.
6. ALTMAN J, DAS GD (1964) Autoradiographic Examination of the Effects of Enriched Environment on the Rate of Glial Multiplication in the Adult Rat Brain. Nature 204: 1161-3.
7. ALTMAN J, DAS G (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 124: 319-35.
8. ÁLVAREZ-BUYLLA A, GARCÍA-VERDUGO JM (2002) Neurogenesis in adult subventricular zone. J Neurosci 22: 629-34.
9. ÁLVAREZ-DOLADO M, PARDAL R, GARCÍA-VERDUGO JM, FIKE JR, LEE HO, PFEFFER K, LOIS C, MORRISON SJ, ÁLVAREZBUYLLA A (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425: 968-73.
10. ARNETT HA, FANCY SP, ALBERTA JA, ZHAO C, PLANT SR, KAING S, RAINE CS, ROWITCH DH, FRANKLIN RJ, STILES CD (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306: 2111-5.
11. ARTAVANIS-TSAKONAS S, RAND MD, LAKE RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284: 770-6.
12. ASCHERIO A, MUNGER KL, SIMON KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9: 599-612.
13. BAI L, LENNON DP, EATON V, MAIER K, CAPLAN AI, MILLER SD, MILLER RH (2009) Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57: 1192-203.
14. BAI L, LENNON DP, CAPLAN AI, DECHANT A, HECKER J, KRANSO J, ZAREMBA A, MILLER RH (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nature neuroscience.
15. BARHUM Y, GAI-CASTRO S, BAHAT-STROMZA M, BARZILAY R, MELAMED E, OFFEN D (2010) Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci 41: 129-37.
16. BARRES BA, LAZAR MA, RAFF MC (1994) A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120: 1097-1108.
17. BILLON N, TOKUMOTO Y, FORREST D, RAFF M (2001) Role of Thyroid Hormone Receptors in Timing Oligodendrocyte Differentiation. Developmental Biology 235: 110-120.
18. BLAKEMORE WF (1972) Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol 1: 413-26.
19. BLAKEMORE WF (1973) Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20: 63-72.
20. BLAKEMORE WF (1974) Pattern of remyelination in the CNS. Nature 249: 577-8.
21. BRUCE CC, ZHAO C, FRANKLIN RJ (2010) Remyelination - An effective means of neuroprotection. Horm Behav 57: 56-62.
22. CALZA L, FERNÁNDEZ M, GIULIANI A, ALOE L, GIARDINO L (2002) Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 99: 3258-3263.
23. CALZÀ L, FERNÁNDEZ M, GIULIANI A, D'INTINO G, PIRONDI S, SIVILIA S, PARADISI M, DESORDI N, GIARDINO L (2005) Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Research Reviews 48: 339-346.
24. CARLETON A, PETREANU LT, LANSFORD R, ÁLVAREZ-BUYLLA A, LLEDO P-M (2003) Becoming a new neuron in the adult olfactory bulb. Nat Neurosci 6: 507-518.
25. CHANG A, TOURTELLOTTE WW, RUDICK R, TRAPP BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-73.
26. CHEN TS, LAI RC, LEE MM, CHOO AB, LEE CN, LIM SK (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38: 215-24.
27. CONNICK P, KOLAPPAN M, CRAWLEY C, WEBBER DJ, PATANI R, MICHELL AW, DU MQ, LUAN SL, ALTMANN DR, THOMPSON AJ, COMPSTON A, SCOTT MA, MILLER DH, CHANDRAN S (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet neurology 11: 150-6.
28. CRISTOFANILLI M, HARRIS VK, ZIGELBAUM A, GOOSSENS AM, LU A, ROSENTHAL H, SADIQ SA (2011) Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice. Stem cells and development 20: 2065-76.
29. CROCKETT DP, BURSHTEYN M, GARCIA C, MUGGIRONI M, CASACCIA-BONNEFIL P (2005) Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1. Glia 49: 301-8.
30. DA SILVA MEIRELLES L, CHAGASTELLES PC, NARDI NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-13.
31. DAWSON MR, LEVINE JM, REYNOLDS R (2000) NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? J Neurosci Res 61: 471-9.
32. DE CASTRO F, BRIBIAN A (2005) The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev 49: 227-41.
33. DE JAGER PL, BAECHER-ALLAN C, MAIER LM, ARTHUR AT, OTTOBONI L, BARCELLOS L, MCCAULEY JL, SAWCER S, GORIS A, SAARELA J, YELENSKY R, PRICE A, LEPPA V, PATTERSON N, DE BAKKER PI, TRAN D, AUBIN C, POBYWAJLO S, ROSSIN E, HU X, ASHLEY CW, CHOY E, RIOUX JD, PERICAK-VANCE MA, IVINSON A, BOOTH DR, STEWART GJ, PALOTIE A, PELTONEN L, DUBOIS B, HAINES JL, WEINER HL, COMPSTON A, HAUSER SL, DALY MJ, REICH D, OKSENBERG JR, HAFLER DA (2009) The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A 106: 5264-9.
34. DENG W, OBROCKA M, FISCHER I, PROCKOP DJ (2001) In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 282: 148-52.
35. DEZAWA M, TAKAHASHI I, ESAKI M, TAKANO M, SAWADA H (2001) Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 14: 1771-6.
36. DOETSCH F, SCHARFF C (2001) Challenges for Brain Repair: Insights from Adult Neurogenesis in Birds and Mammals. Brain, Behavior and Evolution 58: 306-322.
37. DUSART I, MARTY S, PESCHANSKI M (1992) Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system. Neuroscience 51: 137-48.
38. EBERS GC, SADOVNICK AD (1993) The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 12: 1-5.
39. EBERS GC, SADOVNICK AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54: 1-17.
40. FANCY SP, ZHAO C, FRANKLIN RJ (2004) Increased expression of Nkx2. 2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27: 247-54.
41. FANCY SP, BARANZINI SE, ZHAO C, YUK DI, IRVINE KA, KAING S, SANAI N, FRANKLIN RJ, ROWITCH DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23: 1571-85.
42. FANCY SP, HARRINGTON EP, YUEN TJ, SILBEREIS JC, ZHAO C, BARANZINI SE, BRUCE CC, OTERO JJ, HUANG EJ, NUSSE R, FRANKLIN RJ, ROWITCH DH (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14: 1009-16.
43. FELTS PA, WOOLSTON AM, FERNANDO HB, ASQUITH S, GREGSON NA, MIZZI OJ, SMITH KJ (2005) Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128: 1649-66.
44. FRANCO PG, SILVESTROFF L, SOTO EF, PASQUINI JM (2008) Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination. Experimental Neurology 212: 458-467.
45. FRANKLIN RJ (2002) Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3: 705-14.
46. FRANKLIN RJ, HINKS GL (1999) Understanding CNS remyelination: clues from developmental and regeneration biology. J Neurosci Res 58: 207-13.
47. FRANKLIN RJ, FFRENCH-CONSTANT C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9: 839-55.
48. FRANKLIN RJ, KOTTER MR (2008) The biology of CNS remyelination: the key to therapeutic advances. J Neurol 255 Suppl 1: 19-25.
49. FREEDMAN MS, BAR-OR A, ATKINS HL, KARUSSIS D, FRASSONI F, LAZARUS H, SCOLDING N, SLAVIN S, LE BLANC K, UCCELLI A (2010) The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 16: 503-10.
50. FUGGER L, FRIESE MA, BELL JI (2009) From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol 9: 408-17.
51. FULLER ML, DECHANT AK, ROTHSTEIN B, CAPRARIELLO A, WANG R, HALL AK, MILLER RH (2007) Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 62: 288-300.
52. GAGE FH (2000) Mammalian Neural Stem Cells. Science 287: 1433-1438.
53. GENSERT JM, GOLDMAN JE (1997) Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19: 197-203.
54. GERDONI E, GALLO B, CASAZZA S, MUSIO S, BONANNI I, PEDEMONTE E, MANTEGAZZA R, FRASSONI F, MANCARDI G, PEDOTTI R, UCCELLI A (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61: 219-27.
55. GIVOGRI MI, COSTA RM, SCHONMANN V, SILVA AJ, CAMPAGNONI AT, BONGARZONE ER (2002) Central nervous system myelination in mice with deficient expression of Notch1 receptor. J Neurosci Res 67: 309-20.
56. GONZÁLEZ-PÉREZ O, ROMERO-RODRÍGUEZ R, SORIANO-NAVARRO M, GARCÍA-VERDUGO JM, ÁLVAREZ-BUYLLA A (2009) Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells 27: 2032-43.
57. GORDON D, PAVLOVSKA G, UNEY JB, WRAITH DC, SCOLDING NJ (2010) Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis. J Neuropathol Exp Neurol.
58. GORDON D, PAVLOVSKA G, GLOVER CP, UNEY JB, WRAITH D, SCOLDING NJ (2008) Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci Lett 448: 71-3.
59. GRIGORIADIS N, LOURBOPOULOS A, LAGOUDAKI R, FRISCHER JM, POLYZOIDOU E, TOULOUMI O, SIMEONIDOU C, DERETZI G, KOUNTOURAS J, SPANDOU E, KOTTA K, KARKAVELAS G, TASCOS N, LASSMANN H (2011) Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. Experimental neurology 230: 78-89.
60. HEDSTROM AK, BAARNHIELM M, OLSSON T, ALFREDSSON L (2009) Tobacco smoking, but not Swedish snuffuse, increases the risk of multiple sclerosis. Neurology 73: 696-701.
61. HEINEN A, KREMER D, GOTTLE P, KRUSE F, HASSE B, LEHMANN H, HARTUNG HP, KURY P (2008) The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. Proc Natl Acad Sci U S A 105: 8748-53.
62. HOFSTETTER CP, SCHWARZ EJ, HESS D, WIDENFALK J, EL MANIRA A, PROCKOP DJ, OLSON L (2002) Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 99: 2199-204.
63. JABLONSKA B, AGUIRRE A, RAYMOND M, SZABO G, KITABATAKE Y, SAILOR KA, MING GL, SONG H, GALLO V (2010) Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat Neurosci 13: 541-50.
64. JACKSON EL, GARCÍA-VERDUGO JM, GIL-PEROTIN S, ROY M, QUINONES-HINOJOSA A, VANDENBERG S, ÁLVAREZ-BUYLLA A (2006) PDGFR[alpha]-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling. Neuron 51: 187-199.
65. JADASZ JJ, RIVERA FJ, TAUBERT A, KANDASAMY M, SANDNER B, WEIDNER N, AKTAS O, HARTUNG HP, AIGNER L, KURY P (2012) p57kip2 regulates glial fate decision in adult neural stem cells. Development 139: 3306-15.
66. JARRIAULT S, LE BAIL O, HIRSINGER E, POURQUIE O, LOGEAT F, STRONG CF, BROU C, SEIDAH NG, ISRA L A (1998) Delta-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol 18: 7423-31.
67. JESSEN KR, MIRSKY R (2008) Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56: 1552-65.
68. KABAT EA, WOLF A, BEZER AE, MURRAY JP (1951) Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. J Exp Med 93: 615-33.
69. KAGEYAMA R, OHTSUKA T (1999) The Notch-Hes pathway in mammalian neural development. Cell Res 9: 179-88.
70. KAGEYAMA R, OHTSUKA T, HATAKEYAMA J, OHSAWA R (2005) Roles of bHLH genes in neural stem cell differentiation. Exp Cell Res 306: 343-8.
71. KARUSSIS D, KASSIS I, KURKALLI BG, SLAVIN S (2008) Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 265: 131-5.
72. KASSIS I, GRIGORIADIS N, GOWDA-KURKALLI B, MIZRACHI-KOL R, BEN-HUR T, SLAVIN S, ABRAMSKY O, KARUSSIS D (2008) Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65: 753-61.
73. KEIRSTEAD HS, LEVINE JM, BLAKEMORE WF (1998) Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22: 161-70.
74. KEMP K, GORDON D, WRAITH DC, MALLAM E, HARTFIELD E, UNEY J, WILKINS A, SCOLDING N (2010) Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathol Appl Neurobiol.
75. KESTERSON JW, CARLTON WW (1971) Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema. Exp Mol Pathol 15: 82-96.
76. KOMOLY S, JEYASINGHAM MD, PRATT OE, LANTOS PL (1987) Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. J Neurol Sci 79: 141-8.
77. KOPEN GC, PROCKOP DJ, PHINNEY DG (1999) Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96: 10711-6.
78. KOPER J, HOEBEN R, HOCHSTENBACH F, VAN GOLDE L, LOPES-CARDOZO M (1986) Effects of triiodothyronine on the synthesis of sulfolipids by oligodendrocyte-enriched glial cultures. Biochim Biophys Acta. 887: 327-34.
79. KORNEK B, LASSMANN H (2003) Neuropathology of multiple sclerosis-new concepts. Brain Res Bull 61: 321-6.
80. KREMER D, HEINEN A, JADASZ J, GÖTTLE P, ZIMMERMANN K, ZICKLER P, JANDER S, HARTUNG H-P, KÜRY P (2009) p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation. Proceedings of the National Academy of Sciences 106: 9087-9092.
81. KUCHROO VK, ANDERSON AC, WALDNER H, MUNDER M, BETTELLI E, NICHOLSON LB (2002) T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol 20: 101-23.
82. KUHLMANN T, MIRON V, CUO Q, WEGNER C, ANTEL J, BRUCK W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131: 1749-58.
83. LANZA C, MORANDO S, VOCI A, CANESI L, PRINCIPATO MC, SERPERO LD, MANCARDI G, UCCELLI A, VERGANI L (2009) Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem 110: 1674-84.
84. LARSEN PH, WELLS JE, STALLCUP WB, OPDENAKKER G, YONG VW (2003) Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23: 11127-35.
85. LASSMANN H (1998) Neuropathology in multiple sclerosis: new concepts. Mult Scler 4: 93-8.
86. LASSMANN H (1999) Mechanisms of demyelination and tissue damage in multiple sclerosis. Acta Neurol Belg 99: 6-10.
87. LASSMANN H (2007a) Experimental models of multiple sclerosis. Rev Neurol (Paris) 163: 651-5.
88. LASSMANN H (2007b) Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci 259: 3-6.
89. LASSMANN H, BRUCK W, LUCCHINETTI CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210-8.
90. LASSMANN H, BRUCK W, LUCCHINETTI C, RODRÍGUEZ M (1997) Remyelination in multiple sclerosis. Mult Scler 3: 133-6.
91. LEVINE JM, REYNOLDS R (1999) Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp Neurol 160: 333-47.
92. LEVINE JM, REYNOLDS R, FAWCETT JW (2001) The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24: 39-47.
93. LI Y, CHEN J, WANG L, ZHANG L, LU M, CHOPP M (2001) Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316: 67-70.
94. LI Y, CHOPP M, CHEN J, WANG L, GAUTAM SC, XU YX, ZHANG Z (2000) Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20: 1311-9.
95. LIU XJ, ZHANG JF, SUN B, PENG HS, KONG QF, BAI SS, LIU YM, WANG GY, WANG JH, LI HL (2009) Reciprocal effect of mesenchymal stem cell on experimental autoimmune encephalomyelitis is mediated by transforming growth factor-beta and interleukin-6. Clin Exp Immunol 158: 37-44.
96. LIU Y, RAO MS (2004) Glial progenitors in the CNS and possible lineage relationships among them. Biol Cell 96: 279-90.
97. LOIS C, GARCÍA-VERDUGO JM, ÁLVAREZ-BUYLLA A (1996) Chain migration of neuronal precursors. Science 271: 978-81.
98. LU P, BLESCH A, TUSZYNSKI MH (2004) Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 77: 174-91.
99. LU P, JONES LL, TUSZYNSKI MH (2005) BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 191: 344-60.
100. LU Z, HU X, ZHU C, WANG D, ZHENG X, LIU Q (2009) Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J Neuroimmunol 206: 58-69.
101. LUBLIN FD, REINGOLD SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46: 907-11.
102. LUDWIN SK (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest 39: 597-612.
103. LUDWIN SK, MAITLAND M (1984) Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths. J Neurol Sci 64: 193-8.
104. MAHMOOD A, LU D, WANG L, LI Y, LU M, CHOPP M (2001) Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 49: 1196-203; discussion 1203-4.
105. MARTINO G, FRANKLIN RJ, VAN EVERCOOREN AB, KERR DA (2010) Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol 6: 247-55.
106. MATSUSHIMA GK, MORELL P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-16.
107. MENN B, GARCÍA-VERDUGO JM, YASCHINE C, GONZÁLEZ-PÉREZ O, ROWITCH D, ÁLVAREZ-BUYLLA A (2006) Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26: 7907-18.
108. MILLER RH (2002) Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 67: 451-67.
109. MINGUELL JJ, ERICES A, CONGET P (2001) Mesenchymal stem cells. Exp Biol Med (Maywood) 226: 507-20.
110. MUNOZ-ELÍAS G, WOODBURY D, BLACK IB (2003) Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells 21: 437-48.
111. MURTIE JC, ZHOU YX, LE TQ, VANA AC, ARMSTRONG RC (2005) PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 19: 171-82.
112. NAIT-OUMESMAR B, DECKER L, LACHAPELLE F, AVELLANA-ADALID V, BACHELIN C, VAN EVERCOOREN AB (1999) Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 11: 4357-66.
113. NAIT-OUMESMAR B, PICARD-RIERA N, KERNINON C, DECKER L, SEILHEAN D, HOGLINGER GU, HIRSCH EC, REYNOLDS R, BARON-VAN EVERCOOREN A (2007) Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 104: 4694-9.
114. NEMETH K, LEELAHAVANICHKUL A, YUEN PS, MAYER B, PARMELEE A, DOI K, ROBEY PG, LEELAHAVANICHKUL K, KOLLER BH, BROWN JM, HU X, JELINEK I, STAR RA, MEZEY E (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-9.
115. NEUHUBER B, TIMOTHY HIMES B, SHUMSKY JS, GALLO G, FISCHER I (2005) Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035: 73-85.
116. NEUHUBER B, GALLO G, HOWARD L, KOSTURA L, MACKAY A, FISCHER I (2004) Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 77: 192-204.
117. NIEHAUS A, SHI J, GRZENKOWSKI M, DIERS-FENGER M, ARCHELOS J, HARTUNG HP, TOYKA K, BRUCK W, TROTTER J (2000) Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann Neurol 48: 362-71.
118. NOSEWORTHY JH, LUCCHINETTI C, RODRÍGUEZ M, WEINSHENKER BG (2000) Multiple sclerosis. N Engl J Med 343: 938-52.
119. OHTSUKA T, SAKAMOTO M, GUILLEMOT F, KAGEYAMA R (2001) Roles of the basic helix-loop-helix genes Hes1 and Hes5 in expansion of neural stem cells of the developing brain. J Biol Chem 276: 30467-74.
120. OLAH M, AMOR S, BROUWER N, VINET J, EGGEN B, BIBER K, BODDEKE HW (2012) Identification of a microglia phenotype supportive of remyelination. Glia 60: 306-21.
121. ORTON SM, HERRERA BM, YEE IM, VALDAR W, RAMAGOPALAN SV, SADOVNICK AD, EBERS GC (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5: 932-6.
122. PADOVAN CS, JAHN K, BIRNBAUM T, REICH P, SOSTAK P, STRUPP M, STRAUBE A (2003) Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant 12: 839-48.
123. PICARD-RIERA N, DECKER L, DELARASSE C, GOUDE K, NAIT-OUMESMAR B, LIBLAU R, PHAM-DINH D, EVERCOOREN AB (2002) Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A 99: 13211-6.
124. RAFEI M, BIRMAN E, FORNER K, GALIPEAU J (2009a) Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol Ther 17: 1799-803.
125. RAFEI M, CAMPEAU PM, AGUILAR-MAHECHA A, BUCHANAN M, WILLIAMS P, BIRMAN E, YUAN S, YOUNG YK, BOIVIN MN, FORNER K, BASIK M, GALIPEAU J (2009b) Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 182: 5994-6002.
126. RAFF MC, MILLER RH, NOBLE M (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303: 390-6.
127. RAFF MC, WILLIAMS BPA, MILLER RH (1984) The in vitro differentiation of a bipotential glial progenitor cell. EMBO J. 3: 1857-1864.
128. RAFF MC, LILLIEN LE, RICHARDSON WD, BURNE JF, NOBLE MD (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565.
129. RAMAGOPALAN SV, DOBSON R, MEIER UC, GIOVANNONI G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9: 727-39.
130. REDWINE JM, ARMSTRONG RC (1998) In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol 37: 413-28.
131. REYNOLDS R, DAWSON M, PAPADOPOULOS D, POLITO A, DI BELLO IC, PHAM-DINH D, LEVINE J (2002) The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 31: 523-36.
132. RISMANCHI N, FLOYD CL, BERMAN RF, LYETH BG (2003) Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols. Brain Res 991: 46-55.
133. RIVERA FJ, SIERRALTA WD, MINGUELL JJ, AIGNER L (2006a) Adult hippocampus derived soluble factors induce a neuronal-like phenotype in mesenchymal stem cells. Neurosci Lett 406: 49-54.
134. RIVERA FJ, COUILLARDDESPRES S, PEDRE X, PLOETZ S, CAIONI M, LOIS C, BOGDAHN U, AIGNER L (2006b) Mesenchymal Stem Cells Instruct Oligodendrogenic Fate Decision on Adult Neural Stem Cells. STEM CELLS 24: 2209-2219.
135. RIVERA FJ, KANDASAMY M, COUILLARD-DESPRES S, CAIONI M, SÁNCHEZ R, HUBER C, WEIDNER N, BOGDAHN U, AIGNER L (2008) Oligodendrogenesis of Adult Neural Progenitors: Differential Effects of Ciliary Neurotrophic Factor and Mesenchymal Stem Cell Derived Factors. J Neurochem.
136. RIVERA FJ, STEFFENHAGEN C, KREMER D, KANDASAMY M, SANDNER B, COUILLARD-DESPRES S, WEIDNER N, KURY P, AIGNER L (2010) Deciphering the oligodendrogenic program of neural progenitors: cell intrinsic and extrinsic regulators. Stem Cells Dev 19: 595-606.
137. RIVERA FJ, SIEBZEHNRUBL FA, KANDASAMY M, COUILLARD-DESPRES S, CAIONI M, POEHLER AM, BERNINGER B, SANDNER B, BOGDAHN U, GOETZ M, BLUEMCKE I, WEIDNER N, AIGNER L (2009) Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures. Cell Physiol Biochem 24: 317-24.
138. RIVERS TM, SPRUNT DH, BERRY GP (1933) Observations on Attempts to Produce Acute Disseminated Encephalomyelitis in Monkeys. J Exp Med 58: 39-53.
139. RODRÍGUEZ M (2007) Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Brain Pathol 17: 219-29.
140. RODRÍGUEZ-PEÑA A (1999) Oligodendrocyte development and thyroid hormone. J Neurobiol. 40: 497-512.
141. SADOVNICK AD, EBERS GC (1993) Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 20: 17-29.
142. SADOVNICK AD, EBERS GC, DYMENT DA, RISCH NJ (1996) Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 347: 1728-30.
143. SAJIC M, HUNT DP, LEE W, COMPSTON DA, SCHWEIMER JV, GREGSON NA, CHANDRAN S, SMITH KJ (2012) Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. PloS one 7: e30708.
144. SAMANTA J, KESSLER JA (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131: 4131-42.
145. SÁNCHEZ-RAMOS J, SONG S, CARDOZ-OPELÁEZ F, HAZZI C, STEDEFORD T, WILLING A, FREEMAN TB, SAPORTA S, JANSSEN W, PATEL N, COOPER DR, SANBERG PR (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247-56.
146. SCHONROCK LM, KUHLMANN T, ADLER S, BITSCH A, BRUCK W (1998) Identification of glial cell proliferation in early multiple sclerosis lesions. Neuropathol Appl Neurobiol 24: 320-30.
147. SELMANI Z, NAJI A, ZIDI I, FAVIER B, GAIFFE E, OBERT L, BORG C, SAAS P, TIBERGHIEN P, ROUAS-FREISS N, CAROSELLA ED, DESCHASEAUX F (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26: 212-22.
148. SETOGUCHI T, YONE K, MATSUOKA E, TAKENOUCHI H, NAKASHIMA K, SAKOU T, KOMIYA S, IZUMO S (2001) Traumatic injury-induced BMP7 expression in the adult rat spinal cord. Brain Res 921: 219-25.
149. SHIMIZU T, KAGAWA T, WADA T, MUROYAMA Y, TAKADA S, IKENAKA K (2005) Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev Biol 282: 397-410.
150. SIFFRIN V, VOGT J, RADBRUCH H, NITSCH R, ZIPP F (2010) Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci 33: 202-10.
151. SILVESTROFF L, BARTUCCI S, SOTO E, GALLO V, PASQUINI J, FRANCO P (2010) Cuprizone-induced demyelination in CNP::GFP transgenic mice. J Comp Neurol 518: 2261-83.
152. SIM FJ, ZHAO C, PENDERIS J, FRANKLIN RJ (2002) The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22: 2451-9.
153. SKRIPULETZ T, LINDNER M, KOTSIARI A, GARDE N, FOKUHL J, LINSMEIER F, TREBST C, STANGEL M (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172: 1053-61.
154. SMITH KJ, MCDONALD WI, BLAKEMORE WF (1979) Restoration of secure conduction by central demyelination. Trans Am Neurol Assoc 104: 25-9.
155. SOSPEDRA M, MARTIN R (2005) Antigen-specific therapies in multiple sclerosis. Int Rev Immunol 24: 393-413.
156. STEFFENHAGEN C, DECHANT FX, OBERBAUER E, FURTNER T, WEIDNER N, KURY P, AIGNER L, RIVERA FJ (2011) Mesenchymal Stem Cells Prime Proliferating Adult Neural Progenitors Toward an Oligodendrocyte Fate. Stem cells and development.
157. SVEJGAARD A (2008) The immunogenetics of multiple sclerosis. Immunogenetics 60: 275-86.
158. TANIGAKI K, NOGAKI F, TAKAHASHI J, TASHIRO K, KUROOKA H, HONJO T (2001) Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate. Neuron 29: 45-55.
159. TERADA N, HAMAZAKI T, OKA M, HOKI M, MASTALERZ DM, NAKANO Y, MEYER EM, MOREL L, PETERSEN BE, SCOTT EW (2002) Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-5.
160. UCCELLI A, PISTOIA V, MORETTA L (2007) Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28: 219-26.
161. UCCELLI A, ZAPPIA E, BENVENUTO F, FRASSONI F, MANCARDI G (2006) Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 6: 17-22.
162. WANG S, SDRULLA AD, DISIBIO G, BUSH G, NOFZIGER D, HICKS C, WEINMASTER G, BARRES BA (1998) Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63-75.
163. WATANABE M, TOYAMA Y, NISHIYAMA A (2002) Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69: 826-36.
164. WHITACRE CC (2001) Sex differences in autoimmune disease. Nat Immunol 2: 777-80.
165. WILSON HC, SCOLDING NJ, RAINE CS (2006) Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 176: 162-73.
166. WOLSWIJK G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18: 601-9.
167. WOLSWIJK G, NOBLE M (1989) Identification of an adult-specific glial progenitor cell. Development 105: 387-400.
168. WOODBURY D, REYNOLDS K, BLACK IB (2002) Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 69: 908-17.
169. WOODBURY D, SCHWARZ EJ, PROCKOP DJ, BLACK IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364-70.
170. WOODHOO A, ALONSO MB, DROGGITI A, TURMAINE M, D'ANTONIO, PARKINSON DB, WILTON DK, AL-SHAWI R, SIMONS P, SHEN J, GUILLEMOT F, RADTKE F, MEIJER D, FELTRI ML, WRABETZ L, MIRSKY R, JESSEN KR (2009) Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat Neurosci 12: 839-47.
171. WOODRUFF RH, FRANKLIN RJ (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25: 216-28.
172. WOODRUFF RH, FRUTTIGER M, RICHARDSON WD, FRANKLIN RJM (2004) Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Molecular and Cellular Neuroscience 25: 252-262.
173. WU Y, LIU Y, LEVINE EM, RAO MS (2003) Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors. Dev Dyn 226: 675-89.
174. ZAPPIA E, CASAZZA S, PEDEMONTE E, BENVENUTO F, BONANNI I, GERDONI E, GIUNTI D, CERAVOLO A, CAZZANTI F, FRASSONI F, MANCARDI G, UCCELLI A (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-61.
175. ZAWADZKA M, RIVERS LE, FANCY SP, ZHAO C, TRIPATHI R, JAMEN F, YOUNG K, GONCHAREVICH A, POHL H, RIZZI M, ROWITCH DH, KESSARIS N, SUTER U, RICHARDSON WD, FRANKLIN RJ (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6: 578-90.
176. ZHANG J, LI Y, CHEN J, YANG M, KATAKOWSKI M, LU M, CHOPP M (2004) Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 1030: 19-27.
177. ZHANG J, LI Y, LU M, CUI Y, CHEN J, NOFFSINGER L, ELIAS SB, CHOPP M (2006) Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 84: 587-95.
178. ZHANG J, LI Y, CHEN J, CUI Y, LU M, ELIAS SB, MITCHELL JB, HAMMILL L, VANGURI P, CHOPP M (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195: 16-26.
179. ZHANG J, BRODIE C, LI Y, ZHENG X, ROBERTS C, LU M, GAO Q, BORNEMAN J, SAVANT-BHONSALE S, ELIAS SB, CHOPP M (2009) Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis. J Neurol Sci 279: 30-8.
180. ZHANG SC, GE B, DUNCAN ID (1999) Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci U S A 96: 4089-94.
181. ZHOU YX, FLINT NC, MURTIE JC, LE TQ, ARMSTRONG RC (2006) Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation. Glia 54: 578-90.